These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 6370421)
21. [Immunohistochemical study of new monoclonal antibodies--E29, 115D8 --to an epithelial membrane antigen (EMA) in ovarian tumors]. Fujimoto I; Fukuda K; Hang SP; Hasumi K; Masubuchi K; Osamura Y; Watanabe K Gan No Rinsho; 1987 Nov; 33(14):1798-804. PubMed ID: 2826841 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. Rodríguez-Burford C; Barnes MN; Berry W; Partridge EE; Grizzle WE Gynecol Oncol; 2001 Jun; 81(3):373-9. PubMed ID: 11371125 [TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347 [TBL] [Abstract][Full Text] [Related]
24. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649 [TBL] [Abstract][Full Text] [Related]
25. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity. Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106 [TBL] [Abstract][Full Text] [Related]
26. Production and characterization of monoclonal antibody to a 60-kD glycoprotein in ovarian carcinoma. Bhattacharya M; Chatterjee SK; Gangopadhyay A; Barlow JJ Hybridoma; 1985; 4(2):153-62. PubMed ID: 3891588 [TBL] [Abstract][Full Text] [Related]
27. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732 [TBL] [Abstract][Full Text] [Related]
28. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites. Barker SD; Casado E; Gomez-Navarro J; Xiang J; Arafat W; Mahasreshti P; Pustilnik TB; Hemminki A; Siegal GP; Alvarez RD; Curiel DT Gynecol Oncol; 2001 Jul; 82(1):57-63. PubMed ID: 11426962 [TBL] [Abstract][Full Text] [Related]
29. Expression of tumor-associated glycoprotein 72 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Myers RB; Schlom J; Srivastava S; Grizzle WE Mod Pathol; 1995 Apr; 8(3):260-5. PubMed ID: 7617651 [TBL] [Abstract][Full Text] [Related]
30. Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer. Provencher DM; Finstad CL; Saigo PE; Rubin SC; Hoskins WJ; Federici MG; Stockert E; Lloyd KO; Lewis JL Gynecol Oncol; 1993 Jul; 50(1):78-83. PubMed ID: 8349167 [TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical detection of ovarian carcinoma cells in serous effusions. Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129 [TBL] [Abstract][Full Text] [Related]
32. Detection of adenocarcinoma in peritoneal washings by staining with monoclonal antibody B72.3. Szpak CA; Soper JT; Thor A; Schlom J; Johnston WW Acta Cytol; 1989; 33(2):205-14. PubMed ID: 2648721 [TBL] [Abstract][Full Text] [Related]
33. HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy. Younes M; Katikaneni PR; Lechago LV; Lechago J Mod Pathol; 1994 Apr; 7(3):396-400. PubMed ID: 8058715 [TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Atkinson BF; Ernst CS; Herlyn M; Steplewski Z; Sears HF; Koprowski H Cancer Res; 1982 Nov; 42(11):4820-3. PubMed ID: 6751528 [TBL] [Abstract][Full Text] [Related]
35. Association of antigen expression and DNA ploidy in human colorectal tumors. Durrant LG; Robins RA; Armitage NC; Brown A; Baldwin RW; Hardcastle JD Cancer Res; 1986 Jul; 46(7):3543-9. PubMed ID: 3518917 [TBL] [Abstract][Full Text] [Related]
36. Density distribution, cytomorphologic features and immunologic characteristics of ovarian and endometrial clear cell carcinomas. Harłozińska A; Rabczyński J; Bar JK; Richter R Acta Cytol; 1990; 34(5):657-63. PubMed ID: 2220244 [TBL] [Abstract][Full Text] [Related]
37. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
38. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925 [TBL] [Abstract][Full Text] [Related]
39. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer. Tagliabue E; Mènard S; Della Torre G; Barbanti P; Mariani-Costantini R; Porro G; Colnaghi MI Cancer Res; 1985 Jan; 45(1):379-85. PubMed ID: 3965146 [TBL] [Abstract][Full Text] [Related]
40. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer. Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]